CrizotinibDevelopment of crizotinib resistance: case report.

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1820卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82933-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：113 / 113

相关论文

共 50 条

[41] Crizotinib/erlotinibDrug resistance, vomiting and rash: case report
Reactions Weekly, 2017, 1678 (1) : 66 - 66
[42] Crizotinib/icotinibDrug resistance and various toxicities: case report
Reactions Weekly, 2019, 1781 (1) : 122 - 122
[43] Crizotinib/gefitinib/osimertinibDrug resistance and rash: case report
Reactions Weekly, 2019, 1763 (1) : 117 - 117
[44] Crizotinib/pemetrexedAcquired drug resistance and neutropenia: case report
Reactions Weekly, 2015, 1555 (1) : 66 - 66
[45] Crizotinib/nivolumab/tepotinibNausea and drug resistance: case report
Reactions Weekly, 2021, 1877 (1) : 122 - 122
[46] Crizotinib/gefitinib/osimertinibEmergence of drug resistance: case report
Reactions Weekly, 2021, 1873 (1) : 86 - 86
[47] Hereditary resistance to oral anticoagulants:: a case report.
Paganelli, F
Conard, J
Gelisse, R
Ricard, P
Samama, M
Lévy, S
ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1999, 92 (06): : 757 - 759
[48] CrizotinibDevelopment of drug resistance in Anaplastic lymphoma kinase (ALK) fusion adenocarcinoma: case report
Reactions Weekly, 2017, 1668 (1) : 131 - 131
[49] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1733 (1) : 121 - 121
[50] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
Reactions Weekly, 2016, 1616 (1) : 15 - 15

← 1 2 3 4 5 →